Metformin therapy and circulating NT-proBNP levels: the CAMERA trial

Metformin therapy and circulating NT-proBNP levels: the CAMERA trial

Bibliográfalaš dieđut
Váldodahkkit:	Preiss, D, Welsh, P, Sattar, N
Materiálatiipa:	Journal article
Almmustuhtton:	American Diabetes Association 2016

Geahča maid

The integration of BNP and NT-proBNP into clinical medicine
Dahkki: Swiss Medical Weekly
Almmustuhtton: (2007-01-01)

Urinary NT-proBNP compared head-to-head to plasmatic NT-proBNP in a real life collective with an ICD
Dahkki: Benedikt Seither, et al.
Almmustuhtton: (2024-11-01)

In-hospital mortality is associated with high NT-proBNP level.
Dahkki: Malik Benmachiche, et al.
Almmustuhtton: (2018-01-01)

Sendaway capillary NT-proBNP in pulmonary hypertension
Dahkki: Eleanor Morris, et al.
Almmustuhtton: (2024-07-01)

The Role of NT-proBNP Levels in the Diagnosis of Hypertensive Heart Disease
Dahkki: Angeliki Mouzarou, et al.
Almmustuhtton: (2025-01-01)

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
Dahkki: A Palazzuoli, et al.
Almmustuhtton: (2010-05-01)

Highly sensitive detection of NT-proBNP by molecular motor
Dahkki: Jie Zhang, et al.
Almmustuhtton: (2017-03-01)

The Potential Role of Salivary NT-proBNP in Heart Failure
Dahkki: Aidonis Rammos, et al.
Almmustuhtton: (2023-08-01)

Serum NT-ProBNP potential marker of cirrhotic cardiomyopathy
Dahkki: Maya Risteska, et al.
Almmustuhtton: (2022-10-01)

NT-proBNP and prognostics variables in acute myocardial infarction
Dahkki: Jorge Vendrell Cabrera, et al.
Almmustuhtton: (2012-01-01)

The association of plasma NT-proBNP level and progression of diabetic kidney disease
Dahkki: Yuancheng Zhao, et al.
Almmustuhtton: (2023-12-01)

Association between NT-proBNP Level and the Severity of COVID-19 Pneumonia
Dahkki: Lan Wang, et al.
Almmustuhtton: (2021-01-01)

Serum NT-proBNP levels as a marker for cardiopulmonary function in preeclampsia
Dahkki: H.M. Kim, et al.
Almmustuhtton: (2020-08-01)

BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
Dahkki: Robert A. Lewis, et al.
Almmustuhtton: (2020-05-01)

SST2 and NT-proBNP biomarkers in prediction of COVID-19
Dahkki: O.O. Samchuk, et al.
Almmustuhtton: (2023-06-01)

NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis
Dahkki: Reinhard Henrik, et al.
Almmustuhtton: (2011-08-01)

The role of NT-proBNP in screening for atrial fibrillation in hypertensive disease
Dahkki: Gina Sado, et al.
Almmustuhtton: (2024-12-01)

NT-proBNP and postoperative heart failure in surgery for aortic stenosis
Dahkki: Huiqi Jiang, et al.
Almmustuhtton: (2019-05-01)

GALECTIN-3 AND NT-proBNP AS BIOMARKERS OF HEART FAILURE DECOMPENSATION
Dahkki: Yu. V. Dubolazova, et al.
Almmustuhtton: (2017-02-01)

Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
Dahkki: Chin-Shern Lau, et al.
Almmustuhtton: (2022-05-01)

LSPR-Based Aptasensor for Rapid Urinary Detection of NT-proBNP
Dahkki: Maria António, et al.
Almmustuhtton: (2023-07-01)

Using NT-proBNP as a criterion for heart failure hospitalization
Dahkki: Babak Tamizifar, et al.
Almmustuhtton: (2012-01-01)

NT-proBNP na estratificação de risco no tromboembolismo pulmonar
Dahkki: Hélder Dores, et al.
Almmustuhtton: (2011-12-01)

The Role of NT-proBNP in the Diagnosis of Ventricular Arrhythmias in Patients with Systemic
Dahkki: Lucian MURESAN, et al.
Almmustuhtton: (2017-06-01)

NT-proBNP in Myocarditis after a Scorpion Sting Envenomation
Dahkki: Suresh V Sagarad, et al.
Almmustuhtton: (2013-01-01)

NT-proBNP and Echocardiographic Parameters in Patients with Acute Heart Failure
Dahkki: Radek Pudil, et al.
Almmustuhtton: (2007-01-01)

The effect of metformin treatment on the level of GLP-1, NT-proBNP and endothelin-1 in patients with type 2 diabetes mellitus
Dahkki: L.K. Sokolova, et al.
Almmustuhtton: (2020-11-01)

Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors
Dahkki: Hussein Alawieh, et al.
Almmustuhtton: (2019-11-01)

The Interplay between Adipose Tissue Properties and Levels of NT-proBNP in People with HIV
Dahkki: Mads-Holger Bang Jacobsen, et al.
Almmustuhtton: (2023-01-01)

Pretransplant NT‐proBNP levels are associated with mortality among lung transplant recipients
Dahkki: Shimon Izhakian, et al.
Almmustuhtton: (2024-07-01)

Changes in NT-proBNP levels in patients with sinus tachycardia after COVID-19
Dahkki: V. I. Podzolkov, et al.
Almmustuhtton: (2023-01-01)

Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease.
Dahkki: Bader Alsuwailem, et al.
Almmustuhtton: (2021-01-01)

A Point-of-Care Measurement of NT-proBNP for Heart Failure Patients
Dahkki: Cesar Navarro, et al.
Almmustuhtton: (2020-01-01)

Longitudinal NT‐proBNP: Associations With Echocardiographic Changes and Outcomes in Heart Failure
Dahkki: Kanako Teramoto, et al.
Almmustuhtton: (2024-05-01)

NT-proBNP, Cardiometabolic Risk Factors, and Nutritional Status in Hemodialysis Patients
Dahkki: Jacques Ducros, et al.
Almmustuhtton: (2017-01-01)

Prognostic value of NT-proBNP in the new era of heart failure treatment.
Dahkki: Dat Vu Nguyen, et al.
Almmustuhtton: (2024-01-01)

Assessment of the Myocardial Stress Biomarker NT-proBNP in Real Clinical Practice
Dahkki: I. A. Kozlov, et al.
Almmustuhtton: (2023-02-01)

Analytical and clinical performance evaluation of a new NT-proBNP assay
Dahkki: Pingfeng Feng, et al.
Almmustuhtton: (2024-07-01)

The importance of NT proBNP in hypertensive patients management for preventing heart failure
Dahkki: Irina Cuciureanu, et al.
Almmustuhtton: (2021-03-01)

NT-proBNP as a neuroendocrine tumor biomarker: beyond heart failure
Dahkki: Paweł Komarnicki, et al.
Almmustuhtton: (2023-09-01)